Terms: = Breast cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR
160 results:
1. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers.
Chen YC; Chen JH; Tsai CF; Wu CT; Chang PC; Yeh WL
Toxicol Appl Pharmacol; 2024 Feb; 483():116818. PubMed ID: 38215994
[TBL] [Abstract] [Full Text] [Related]
3. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative breast cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
[TBL] [Abstract] [Full Text] [Related]
4. M
Liu X; Li P; Huang Y; Li H; Liu X; Du Y; Lin X; Chen D; Liu H; Zhou Y
Redox Biol; 2024 Feb; 69():102993. PubMed ID: 38104484
[TBL] [Abstract] [Full Text] [Related]
5. Enhanced anticancer synergy of LOM612 in combination with selinexor: foxo1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer.
Xu S; Shi Y; Li S
Cancer Chemother Pharmacol; 2024 Mar; 93(3):191-202. PubMed ID: 38051377
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
7. foxo1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation.
Tang L; Wei D; Xu X; Mo D; Cheng D; Yan F
Breast Cancer Res Treat; 2023 Nov; 202(2):397-408. PubMed ID: 37640964
[TBL] [Abstract] [Full Text] [Related]
8. Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/foxo1 pathway.
Yu Y; Hao J; Wang L; Zheng X; Xie C; Liu H; Wu J; Qiao S; Shi J
Pathol Res Pract; 2023 Sep; 249():154766. PubMed ID: 37633006
[TBL] [Abstract] [Full Text] [Related]
9. foxo1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
Pintor S; Lopez A; Flores D; Lozoya B; Soti B; Pokhrel R; Negrete J; Persans MW; Gilkerson R; Gunn B; Keniry M
FEBS Open Bio; 2023 Nov; 13(11):2108-2123. PubMed ID: 37584250
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration.
Cui L; Ye C; Luo T; Jiang H; Lai B; Wang H; Chen Z; Li Y
J Vis Exp; 2023 Jun; (196):. PubMed ID: 37358272
[TBL] [Abstract] [Full Text] [Related]
11. P2Y
Jin H; Ko YS; Yun SP; Park SW; Kim HJ
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37165911
[TBL] [Abstract] [Full Text] [Related]
12. Variable Intrinsic Expression of Immunoregulatory Biomarkers in breast cancer Cell Lines, Mammospheres, and Co-Cultures.
Montoyo-Pujol YG; García-Escolano M; Ponce JJ; Delgado-García S; Martín TA; Ballester H; Castellón-Molla E; Martínez-Peinado P; Pascual-García S; Sempere-Ortells JM; Peiró G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901916
[TBL] [Abstract] [Full Text] [Related]
13. Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145.
Mallet JF; Shahbazi R; Alsadi N; Saleem A; Sobiesiak A; Arnason JT; Matar C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835085
[TBL] [Abstract] [Full Text] [Related]
14. Narrow Leafed Lupin (
Escudero-Feliu J; García-Costela M; Moreno-SanJuan S; Puentes-Pardo JD; Arrabal SR; González-Novoa P; Núñez MI; Carazo Á; Jimenez-Lopez JC; León J
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771230
[TBL] [Abstract] [Full Text] [Related]
15. Overview of the miR-29 family members' function in breast cancer.
Amirian M; Jafari-Nozad AM; Darroudi M; Farkhondeh T; Samarghandian S
Int J Biol Macromol; 2023 Mar; 230():123280. PubMed ID: 36652981
[TBL] [Abstract] [Full Text] [Related]
16. BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells.
Rossi T; Zamponi R; Chirico M; Pisanu ME; Iorio E; Torricelli F; Gugnoni M; Ciarrocchi A; Pistoni M
J Exp Clin Cancer Res; 2023 Jan; 42(1):7. PubMed ID: 36604676
[TBL] [Abstract] [Full Text] [Related]
17. The foxo1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells.
Flores D; Lopez A; Udawant S; Gunn B; Keniry M
FEBS Open Bio; 2023 Feb; 13(2):352-362. PubMed ID: 36602390
[TBL] [Abstract] [Full Text] [Related]
18. ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling.
Hwang HJ; Lee KH; Cho JY
Cancer Sci; 2023 Apr; 114(4):1451-1463. PubMed ID: 36576228
[TBL] [Abstract] [Full Text] [Related]
19. The Pan-cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
[TBL] [Abstract] [Full Text] [Related]
20. Self-assembled DNA nanostructure containing oncogenic miRNA-mediated cell proliferation by downregulation of foxo1 expression.
Kar A; Kumari K; Mishra SK; Subudhi U
BMC Cancer; 2022 Dec; 22(1):1332. PubMed ID: 36539739
[TBL] [Abstract] [Full Text] [Related]
[Next]
